Goldman Sachs’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-2,042
Closed -$20K – 5770
2018
Q2
$20K Sell
2,042
-16,889
-89% -$166K ﹤0.01% 5492
2018
Q1
$176K Sell
18,931
-9,837
-34% -$93.7K ﹤0.01% 5061
2017
Q4
$274K Buy
28,768
+23,386
+435% +$223K ﹤0.01% 5229
2017
Q3
$56K Buy
5,382
+4,640
+625% +$42.8K ﹤0.01% 6228
2017
Q2
$6K Buy
+742
New +$5.57K ﹤0.01% 6686
2016
Q4
– Sell
-557
Closed -$4K – 7070
2016
Q3
$4K Sell
557
-2,227
-80% -$14.2K ﹤0.01% 6937
2016
Q2
$16K Buy
2,784
+557
+25% +$3.69K ﹤0.01% 6776
2016
Q1
$14K Buy
2,227
+371
+20% +$1.99K ﹤0.01% 6835
2015
Q4
$12K Sell
1,856
-2,042
-52% -$12.8K ﹤0.01% 6943
2015
Q3
$23K Sell
3,898
-29,510
-88% -$219K ﹤0.01% 7002
2015
Q2
$292K Sell
33,408
-18,003
-35% -$151K ﹤0.01% 5769
2015
Q1
$411K Buy
+51,411
New +$384K ﹤0.01% 5337
2014
Q4
– Sell
-1,670
Closed -$11K – 7293
2014
Q3
$11K Buy
1,670
+742
+80% +$5.73K ﹤0.01% 7044
2014
Q2
$8K Sell
928
-1,856
-67% -$14.4K ﹤0.01% 6930
2014
Q1
$19K Buy
+2,784
New +$16.9K ﹤0.01% 6687

Other funds holding SEM

Goldman Sachs's SEM Position: Q2 2026 in Review

Goldman Sachs reduced its Select Medical (SEM) stake by 58% in Q2 2026, selling an estimated $19.9M and leaving 871,540 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Goldman Sachs first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $80.5M in Q2 2021. 241 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Goldman Sachs held 871,540 shares of Select Medical worth $14.4M as of Q2 2026.
  • Goldman Sachs sold 1,210,343 Select Medical shares in Q2 2026, an estimated $19.9M.
  • Select Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2948 holding.
  • Goldman Sachs first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Select Medical position peaked at $80.5M in Q2 2021.
  • 241 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.